Page 14 - Pharmacy Practice News Today

MISSISSAUGA, Ontario, May 02, 2023 -- BioSyent Inc. is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian... | May 2, 2023

A new study conducted by researchers from Regenstrief Institute and the universities of South Carolina and Indiana has found that the most commonly prescribed blood pressure medications, taken for at least six months prior to an intensive care unit (ICU) admission, did not protect against developing delirium in the ICU, regardless of patient age, gender, race, co-morbidities or insurance status. Delirium, an acute brain failure, affects approximately seven million hospitalized patients in the U....

To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.

/PRNewswire/ -- Today, the American Pharmacists Association (APhA) announced that Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, has been named the 15th Chief...

Drugs can save lives but it all depends on how they are used and prescribed.

Experts said shortages of medications aren't rare, but the shortage of ADHD medications is in a category of its own.

Researchers are examining opioid prescriptions for adolescents and young adults after major dental procedures. They are working to revise the way doctors prescribe pain medication.

25.04.2023 - BOSTON, April 25, 2023 (GLOBE NEWSWIRE) - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within ... Seite 1

Host Christina Madison, PharmD, BCACP, AAHIVP, sat down with Jeffrey Bratberg, PharmD, FAPhA, a clinical professor in the college of pharmacy at the University of Rhode Island

In one trial of 51 cancer patients, 60% of those who received a single high-dose psilocybin session achieved clinical remission for depression, and 52% did for anxiety.